Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using molecular markers to predict outcome.

The Journal of urology - 1 Nov 2004

Rubin Mark A

Abstract excerpt

PURPOSE: Developing molecular tests to predict prostate cancer progression requires first defining meaningful clinical end points and defining strategies to take advantage of emerging technology. MATERIALS AND METHODS: The select relevant literature was reviewed concerning clinical trials, clinical prostate cancer nomograms, molecular biomarker development and molecular prostate cancer imaging. RESULTS: There is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Biology
Share to Disease Progression
Share to Neoplasm Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Oligonucleotide Array Sequence Analysis

Share to Predictive Value of Tests

Share to Prostatic Neoplasms

Share to Proteomics

Source

Identifiers

PMID: 15535437
DOI: 10.1097/01.ju.0000142448.58831.d9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using molecular markers to predict outcome.PMID 15535437Read ↗

Molecular markers in urologic oncology: prostate cancer.Semantic proximity Read ↗

The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approachesSemantic proximity Read ↗

Molecular prostate cancer pathology: current issues and achievements.Semantic proximity Read ↗

Diagnosis, staging, and risk stratification in prostate cancer: Utilizing diagnostic tools to avoid unnecessary therapies and side effects.Semantic proximity Read ↗

Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer.Semantic proximity Read ↗

Genomic predictors of prostate cancer therapy outcomes.Semantic proximity Read ↗

Genomic Predictors of Outcome in Prostate CancerSemantic proximity Read ↗

Optimizing molecular signatures for predicting prostate cancer recurrenceSemantic proximity Read ↗

Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test.Semantic proximity Read ↗

Defining high-risk prostate cancer: current status.Semantic proximity Read ↗

Identification of Prognostic Biomarkers for Prostate CancerSemantic proximity Read ↗

Early detection of prostate cancer with emphasis on genetic markers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.